CompletedPhase 1NCT00244946

Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma

Studying Angioimmunoblastic T-cell lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Barbara Ann Karmanos Cancer Institute
Principal Investigator
Lawrence G. Lum, MD, DSc
Barbara Ann Karmanos Cancer Institute
Intervention
therapeutic autologous lymphocytes(biological)
Enrollment
15 enrolled
Eligibility
15-70 years · All sexes
Timeline
2004 – 2013

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00244946 on ClinicalTrials.gov

Other trials for Angioimmunoblastic T-cell lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Angioimmunoblastic T-cell lymphoma →

← Back to all trials